title: Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms.
abstract: Streptococcus pneumoniae serotype epidemiology is essential since serotype replacement is a concern when introducing new polysaccharide-conjugate vaccines. A novel PCR-based automated microarray assay was developed to assist in the tracking of the serotypes. Autolysin, pneumolysin and eight genes located in the capsular operon were amplified using multiplex PCR. This step was followed by a tagged fluorescent primer extension step targeting serotype-specific polymorphisms. The tagged primers were then hybridized to a microarray. Results were exported to an expert system to identify capsular serotypes. The assay was validated on 166 cultured S. pneumoniae samples from 63 different serotypes as determined by the Quellung method. We show that typing only 12 polymorphisms located in the capsular operon allows the identification at the serotype level of 22 serotypes and the assignation of 24 other serotypes to a subgroup of serotypes. Overall, 126 samples (75.9%) were correctly serotyped, 14 were assigned to a member of the same serogroup, 8 rare serotypes were erroneously serotyped, and 18 gave negative serotyping results. Most of the discrepancies involved rare serotypes or serotypes that are difficult to discriminate using a DNA-based approach, for example 6A and 6B. The assay was also tested on clinical specimens including 43 cerebrospinal fluid samples from patients with meningitis and 59 nasopharyngeal aspirates from bacterial pneumonia patients. Overall, 89% of specimens positive for pneumolysin were serotyped, demonstrating that this method does not require culture to serotype clinical specimens. The assay showed no cross-reactivity for 24 relevant bacterial species found in these types of samples. The limit of detection for serotyping and S. pneumoniae detection was 100 genome equivalent per reaction. This automated assay is amenable to clinical testing and does not require any culturing of the samples. The assay will be useful for the evaluation of serotype prevalence changes after new conjugate vaccines introduction.
authors.affiliation: Centre de Recherche en Infectiologie and Département de Microbiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Raymond
authors.forename: Nancy
authors.initials: N
authors.lastname: Boucher
authors.forename: Robin
authors.initials: R
authors.lastname: Allary
authors.forename: Lynda
authors.initials: L
authors.lastname: Robitaille
authors.forename: Brigitte
authors.initials: B
authors.lastname: Lefebvre
authors.forename: Cécile
authors.initials: C
authors.lastname: Tremblay
authors.forename: Jacques
authors.initials: J
authors.lastname: Corbeil
authors.forename: Alain
authors.initials: A
authors.lastname: Gervaix
mesh_terms: D016667:Bacterial Capsules / Q000235:genetics*; D017931:DNA Primers / Q000235:genetics; D005453:Fluorescence; D046228:Microarray Analysis / Q000379:methods*; D060885:Multiplex Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000235:genetics*; D012703:Serotyping / Q000379:methods*; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000235:genetics*
chemical_list: D017931:DNA Primers